Exchange arthroplasty for infection. Perspectives from the United Kingdom.
A number of factors are considered with a bearing on outcome assessment and survivorship analysis. The results achieved in more than 440 exchange arthroplasties are discussed. Despite the apparent threefold increased risk of recurred infection associated with a one-stage approach, this statistic is an oversimplification of the many complex factors involved in the analysis of these results and in the decision between a one- and a two-stage approach to treatment, when presented with an infected hip replacement. The authors think that a one-stage approach remains a reasonable alternative, given certain prerequisites.
Elson
R A
RA
Department of Orthopaedics, Northern General Hospital, Sheffield, England.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001178:Arthroplasty / Q000379:methods; D001424:Bacterial Infections / Q000175:diagnosis / Q000401:mortality / Q000517:prevention & control*; D001707:Biopsy, Needle; D001843:Bone Cements; D005500:Follow-Up Studies; D006622:Hip Prosthesis / Q000379:methods*; D006801:Humans; D011474:Prosthesis Design; D016459:Prosthesis-Related Infections / Q000175:diagnosis / Q000401:mortality / Q000517:prevention & control*; D012008:Recurrence; D012086:Reoperation; D017211:Treatment Failure; D006113:United Kingdom
D000900:Anti-Bacterial Agents; D001843:Bone Cements